Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07075445 · ClinicalTrials.gov registry record
Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3
A clinical trial of Long QT Syndrome Type 3 and Long QT Syndrome 2, sponsored by Thryv Therapeutics.
- Recruiting
- Registry status
- 200
- Enrollment target
- 1
- Study location
NCT07075445: Recruiting study of Long QT Syndrome Type 3 and Long QT Syndrome 2, sponsored by Thryv Therapeutics.
NCT07075445 is a study of Long QT Syndrome Type 3 and Long QT Syndrome 2 that is actively recruiting participants, run by Thryv Therapeutics. The registered enrollment target is 200 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07075445, a study of Long QT Syndrome Type 3 and Long QT Syndrome 2, is actively recruiting participants, sponsored by Thryv Therapeutics.
- RECRUITING
- Registry status
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will answer each patient-reported outcome questionnaire only once over a 6-month period. The study will enroll up to 200 participants.
Primary Outcome
Score from the Satisfaction With Life Scale (SWLS)
Conditions Studied
Study Locations (1)
North Carolina
- East Carolina University - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2025-10-27 |
| Est. Completion | 2026-12-01 |
What NCT07075445 shows while recruiting
NCT07075445 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Long QT Syndrome Type 3 appearing as the primary indexed condition, and to 0 interventions.
NCT07075445 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07075445 about?
NCT07075445 is a clinical study titled "Observational Study to Describe Health-Related Quality of Life and Measure Disease Burden Among Patients With Long QT Syndrome Types (LQTS) 2 and 3". This is a cross-sectional observational study designed to assess the disease burden and quality of life in individuals with LQTS 2 and 3. Each participant will answer each patient-reported outcome questionnaire only once over a 6-month period. The study will enroll up to 200 participants.
What is the current status of trial NCT07075445?
This trial is currently recruiting. The enrollment target is 200 participants. The study started on 2025-10-27. Estimated completion is 2026-12-01.
What conditions does trial NCT07075445 study?
This clinical trial studies the following conditions: Long QT Syndrome Type 3, Long QT Syndrome 2.
Who is sponsoring clinical trial NCT07075445?
This trial is sponsored by Thryv Therapeutics, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07075445 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI